report-image

Global Biomedical Materials Market Size By Segmentations, Top Key Players, Trend, Future Development & Forecast 2024-2035

  • PUBLISHED ON
  • 11/23/2022
  • NO OF PAGES
  • 233
  • CATEGORY
  • Healthcare & Life Sciences
The competitive landscape analysis of Covid-19 Impact on Biomedical Materials Market uncovers detailed company profiles, revenue shares, portfolio innovations, regional product footprint, key developmental strategies, pricing structure, target markets, and near-term plans of market leaders. This entire section helps readers gain an essence of what is driving competition and what would help them stand out to win new target markets.

Market estimates and forecast are backed by an extensive primary research, further complemented by on-point secondary research of Covid-19 Impact on Biomedical Materials Market. The research analysts have invested significant time and effort in gathering critical industry information from KIPs such as OEMs, top suppliers and distributors, and government bodies.

Market Segmentations:
Global Covid-19 Impact on Biomedical Materials Market: Top Key Players
Johnson & Johnson
ZimmerBiomet
Medtronic
Abbott Laboratories
Stryker
Boston Scientific
Smith+Nephew
B-Braun
Straumann
Danaher Corporation
Dentsply Sirona
Cook Medical
Terumo
MicroPort
Lepu Medical

Global Covid-19 Impact on Biomedical Materials Market: By Types
Orthopaedic
Cardiac Surgery
Neurosurgery
Plastic Surgery
Other

Global Covid-19 Impact on Biomedical Materials Market: By Applications
Treatment
Health and Beauty

Global Covid-19 Impact on Biomedical Materials Market: Regions/Countries
North America
Europe
China
Japan



Global Covid-19 Impact on Biomedical Materials Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.

Reasons to Purchase Covid-19 Impact on Biomedical Materials Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come

Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Base Year: 2023
Historic Year: 2016-2022
Forecast: 2024-2035
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biomedical Materials Revenue
1.4 Covid-19 Implications on Market by Type
1.4.1 Global Biomedical Materials Market Size Growth Rate by Type: 2022 VS 2030
1.4.2 Orthopaedic
1.4.3 Cardiac Surgery
1.4.4 Neurosurgery
1.4.5 Plastic Surgery
1.4.6 Other
1.5 Market by Application
1.5.1 Global Biomedical Materials Market Share by Application: 2022 VS 2030
1.5.2 Treatment
1.5.3 Health and Beauty
1.6 Coronavirus Disease 2019 (Covid-19): Biomedical Materials Industry Impact
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends
2.1 Covid-19 Implications on Global Biomedical Materials Market Perspective (2016-2030)
2.2 Covid-19 Implications on Global Biomedical Materials Growth Trends by Regions
2.2.1 Biomedical Materials Market Size by Regions: 2016 VS 2022 VS 2030
2.2.2 Biomedical Materials Historic Market Share by Regions (2016-2021)
2.2.3 Biomedical Materials Forecasted Market Size by Regions (2022-2030)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biomedical Materials Market Growth Strategy
2.3.6 Primary Interviews with Key Biomedical Materials Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players
3.1 Global Top Biomedical Materials Players by Market Size
3.1.1 Global Top Biomedical Materials Players by Revenue (2016-2021)
3.1.2 Global Biomedical Materials Revenue Market Share by Players (2016-2021)
3.1.3 Global Biomedical Materials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biomedical Materials Market Concentration Ratio
3.2.1 Global Biomedical Materials Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biomedical Materials Revenue in 2021
3.3 Biomedical Materials Key Players Head office and Area Served
3.4 Key Players Biomedical Materials Product Solution and Service
3.5 Date of Enter into Biomedical Materials Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Type (2016-2030)
4.1 Global Biomedical Materials Historic Market Size by Type (2016-2021)
4.2 Global Biomedical Materials Forecasted Market Size by Type (2022-2030)

5 Covid-19 Implications on Market Size by Application (2016-2030)
5.1 Global Biomedical Materials Market Size by Application (2016-2021)
5.2 Global Biomedical Materials Forecasted Market Size by Application (2022-2030)

6 North America Impact of COVID-19
6.1 North America Biomedical Materials Market Size (2016-2021)
6.2 Biomedical Materials Key Players in North America (2016-2021)
6.3 North America Biomedical Materials Market Size by Type (2016-2021)
6.4 North America Biomedical Materials Market Size by Application (2016-2021)

7 Europe Impact of COVID-19
7.1 Europe Biomedical Materials Market Size (2016-2021)
7.2 Biomedical Materials Key Players in Europe (2016-2021)
7.3 Europe Biomedical Materials Market Size by Type (2016-2021)
7.4 Europe Biomedical Materials Market Size by Application (2016-2021)

8 China Impact of COVID-19
8.1 China Biomedical Materials Market Size (2016-2021)
8.2 Biomedical Materials Key Players in China (2016-2021)
8.3 China Biomedical Materials Market Size by Type (2016-2021)
8.4 China Biomedical Materials Market Size by Application (2016-2021)

9 Japan Impact of COVID-19
9.1 Japan Biomedical Materials Market Size (2016-2021)
9.2 Biomedical Materials Key Players in Japan (2016-2021)
9.3 Japan Biomedical Materials Market Size by Type (2016-2021)
9.4 Japan Biomedical Materials Market Size by Application (2016-2021)

10Key Players Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Details
10.1.2 Johnson & Johnson Business Overview and Its Total Revenue
10.1.3 Johnson & Johnson Biomedical Materials Introduction
10.1.4 Johnson & Johnson Revenue in Biomedical Materials Business (2016-2021)
10.1.5 Johnson & Johnson Recent Development and Reaction to COVID-19
10.2 ZimmerBiomet
10.2.1 ZimmerBiomet Company Details
10.2.2 ZimmerBiomet Business Overview and Its Total Revenue
10.2.3 ZimmerBiomet Biomedical Materials Introduction
10.2.4 ZimmerBiomet Revenue in Biomedical Materials Business (2016-2021)
10.2.5 ZimmerBiomet Recent Development and Reaction to COVID-19
10.3 Medtronic
10.3.1 Medtronic Company Details
10.3.2 Medtronic Business Overview and Its Total Revenue
10.3.3 Medtronic Biomedical Materials Introduction
10.3.4 Medtronic Revenue in Biomedical Materials Business (2016-2021)
10.3.5 Medtronic Recent Development and Reaction to COVID-19
10.4 Abbott Laboratories
10.4.1 Abbott Laboratories Company Details
10.4.2 Abbott Laboratories Business Overview and Its Total Revenue
10.4.3 Abbott Laboratories Biomedical Materials Introduction
10.4.4 Abbott Laboratories Revenue in Biomedical Materials Business (2016-2021)
10.4.5 Abbott Laboratories Recent Development and Reaction to COVID-19
10.5 Stryker
10.5.1 Stryker Company Details
10.5.2 Stryker Business Overview and Its Total Revenue
10.5.3 Stryker Biomedical Materials Introduction
10.5.4 Stryker Revenue in Biomedical Materials Business (2016-2021)
10.5.5 Stryker Recent Development and Reaction to COVID-19
10.6 Boston Scientific
10.6.1 Boston Scientific Company Details
10.6.2 Boston Scientific Business Overview and Its Total Revenue
10.6.3 Boston Scientific Biomedical Materials Introduction
10.6.4 Boston Scientific Revenue in Biomedical Materials Business (2016-2021)
10.6.5 Boston Scientific Recent Development and Reaction to COVID-19
10.7 Smith+Nephew
10.7.1 Smith+Nephew Company Details
10.7.2 Smith+Nephew Business Overview and Its Total Revenue
10.7.3 Smith+Nephew Biomedical Materials Introduction
10.7.4 Smith+Nephew Revenue in Biomedical Materials Business (2016-2021)
10.7.5 Smith+Nephew Recent Development and Reaction to COVID-19
10.8 B-Braun
10.8.1 B-Braun Company Details
10.8.2 B-Braun Business Overview and Its Total Revenue
10.8.3 B-Braun Biomedical Materials Introduction
10.8.4 B-Braun Revenue in Biomedical Materials Business (2016-2021)
10.8.5 B-Braun Recent Development and Reaction to COVID-19
10.9 Straumann
10.9.1 Straumann Company Details
10.9.2 Straumann Business Overview and Its Total Revenue
10.9.3 Straumann Biomedical Materials Introduction
10.9.4 Straumann Revenue in Biomedical Materials Business (2016-2021)
10.9.5 Straumann Recent Development and Reaction to COVID-19
10.10 Danaher Corporation
10.10.1 Danaher Corporation Company Details
10.10.2 Danaher Corporation Business Overview and Its Total Revenue
10.10.3 Danaher Corporation Biomedical Materials Introduction
10.10.4 Danaher Corporation Revenue in Biomedical Materials Business (2016-2021)
10.10.5 Danaher Corporation Recent Development and Reaction to COVID-19
10.11 Dentsply Sirona
10.11.1 Dentsply Sirona Company Details
10.11.2 Dentsply Sirona Business Overview and Its Total Revenue
10.11.3 Dentsply Sirona Biomedical Materials Introduction
10.11.4 Dentsply Sirona Revenue in Biomedical Materials Business (2016-2021)
10.11.5 Dentsply Sirona Recent Development and Reaction to COVID-19
10.12 Cook Medical
10.12.1 Cook Medical Company Details
10.12.2 Cook Medical Business Overview and Its Total Revenue
10.12.3 Cook Medical Biomedical Materials Introduction
10.12.4 Cook Medical Revenue in Biomedical Materials Business (2016-2021)
10.12.5 Cook Medical Recent Development and Reaction to COVID-19
10.13 Terumo
10.13.1 Terumo Company Details
10.13.2 Terumo Business Overview and Its Total Revenue
10.13.3 Terumo Biomedical Materials Introduction
10.13.4 Terumo Revenue in Biomedical Materials Business (2016-2021)
10.13.5 Terumo Recent Development and Reaction to COVID-19
10.14 MicroPort
10.14.1 MicroPort Company Details
10.14.2 MicroPort Business Overview and Its Total Revenue
10.14.3 MicroPort Biomedical Materials Introduction
10.14.4 MicroPort Revenue in Biomedical Materials Business (2016-2021)
10.14.5 MicroPort Recent Development and Reaction to COVID-19
10.15 Lepu Medical
10.15.1 Lepu Medical Company Details
10.15.2 Lepu Medical Business Overview and Its Total Revenue
10.15.3 Lepu Medical Biomedical Materials Introduction
10.15.4 Lepu Medical Revenue in Biomedical Materials Business (2016-2021)
10.15.5 Lepu Medical Recent Development and Reaction to COVID-19

11Analyst's Viewpoints/Conclusions

12Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.

CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $3950

Only Three Thousand Nine Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4950

Only Four Thousand Nine Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5950

Only Five Thousand Nine Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI